home / stock / dtc / dtc news


DTC News and Press, Solo Brands Inc. Class A From 05/14/24

Stock Information

Company Name: Solo Brands Inc. Class A
Stock Symbol: DTC
Market: NYSE
Website: solostove.com

Menu

DTC DTC Quote DTC Short DTC News DTC Articles DTC Message Board
Get DTC Alerts

News, Short Squeeze, Breakout and More Instantly...

DTC - Defence Therapeutics Strengthens and Expands Global Patent Protection on Key Technologies

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the...

DTC - JAKKS Pacific Q1 ER: Mixed Results With Good Outlook For 2025

2024-05-13 07:59:56 ET Summary JAKKS Pacific's Q1 2024 results show mixed performance, with revenue of $90.1M (12% higher than expected) but adjusted EPS of -$1.09 (28% worse than expected). The company had previously anticipated weak results for the first half of 2024 due to a la...

DTC - Solo Brands, Inc. (DTC) Q1 2024 Earnings Call Transcript

2024-05-11 19:05:39 ET Solo Brands, Inc (DTC) Q1 2024 Results Conference Call May 9, 2024 08:30 AM ET Company Participants Bruce Williams - Investor Relations Chris Metz - President, Chief Executive Officer & Director Laura Coffey - Chief Financial Officer ...

DTC - DTC Stock Earnings: Solo Brands Beats Revenue for Q1 2024

2024-05-09 10:53:08 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Solo Brands (NYSE: DTC ) just reported results for the first quarter of 2024. Solo Brands reported earnings per share of 3 cents. The company reported revenue of $85.3...

DTC - Expected US Company Earnings on Thursday, May 9th, 2024

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

DTC - Solo Brands beats top-line and bottom-line estimates; reaffirms FY24 outlook

2024-05-09 06:54:03 ET More on Solo Brands Solo Brands: New CEO Hoping To Reignite Growth Solo Brands: I'm Expecting Further Financial Turbulence In 2024 Solo Brands Non-GAAP EPS of $0.13 misses by $0.04, revenue of $165.32M misses by $0.83M Seeking Alpha...

DTC - Solo Brands Announces First Quarter Results

Reaffirms Full Year 2024 Guidance Solo Brands, Inc. (NYSE: DTC) (“Solo Brands” or “the Company”) today announced its financial results for the three month period ended March 31, 2024. “We are pleased with our first quarter results as sales and adju...

DTC - Pancreatic Cancer: Successful Trial Against Pancreatic Cancer with Defence Therapeutics' ARM-002 Anti-Cancer Vaccine

Vancouver, British Columbia--(Newsfile Corp. - May 1, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce...

DTC - Solo Brands, Inc. First Quarter Fiscal 2024 Financial Results To Be Released Thursday, May 9, 2024

Solo Brands, Inc (NYSE: DTC), ("Solo Brands" or the "Company"), an omni-channel platform of beloved brands Solo Stove , Chubbies , Oru Kayak , ISLE , TerraFlame , and IcyBreeze today announced that it plans to report its first quarter fiscal 2024 financial results on May 9...

DTC - Defence's AccuTOX Anti-Cancer ARM-002 Vaccine Exhibits Potent Antigen Presentation

Vancouver, British Columbia--(Newsfile Corp. - April 23, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announ...

Previous 10 Next 10